help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lajara, R.
Right arrow Articles by Rotwein, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lajara, R.
Right arrow Articles by Rotwein, P.

Journal of Clinical Endocrinology & Metabolism, Vol 70, 687-692, Copyright © 1990 by Endocrine Society

ARTICLES

Low prevalence of insulin-like growth factor-I gene mutations in human growth disorders

R Lajara, JP Galgani Jr, DP Dempsher, DM Bier and P Rotwein
Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110.

In an attempt to identify genetic lesions contributing to human growth disorders, we evaluated a prospectively recruited group of children with growth failure for mutations in the insulin-like growth factor-I (IGF-I) gene. Two complementary approaches were used: Southern blot analysis to examine the large scale organization of the gene, and a solution hybridization, nuclease protection assay to identify small alterations, such as point mutations. From a total of 61 subjects studied, 52 had no organic basis for their short stature. Analysis of chromosomal DNA from these individuals failed to reveal any variation in the IGF-I gene except for a HindIII site polymorphism which maps near the 3' end of the last IGF-I exon. No single nucleotide substitutions were found within IGF-I-coding regions. Since the frequency of the length polymorphism was the same for both normal-sized and short individuals, it is unlikely to be associated with growth abnormalities. Our results suggest that there is minimal DNA sequence variability in the human IGF-I gene and that mutations in IGF-I exons are infrequent causes of growth failure.


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
D. C. Coutinho, R. R. D. Coletta, E. M. F. Costa, P. R. Pachi, M. C. S. Boguszewski, D. Damiani, B. B. Mendonca, I. J. P. Arnhold, and A. A. L. Jorge
Polymorphisms Identified in the Upstream Core Polyadenylation Signal of IGF1 Gene Exon 6 Do Not Cause Pre- and Postnatal Growth Impairment
J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4889 - 4892.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
P. E Mullis
Genetic control of growth
Eur. J. Endocrinol., January 1, 2005; 152(1): 11 - 31.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
G Bonapace, D Concolino, S Formicola, and P Strisciuglio
A novel mutation in a patient with insulin-like growth factor 1 (IGF1) deficiency
J. Med. Genet., December 1, 2003; 40(12): 913 - 917.
[Full Text]

Home page
 Endocr. Rev.Home page
J. Nakae, Y. Kido, and D. Accili
Distinct and Overlapping Functions of Insulin and IGF-I Receptors
Endocr. Rev., December 1, 2001; 22(6): 818 - 835.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1990 by The Endocrine Society